The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
Abstract
Patients with acromegaly have a reduced life expectancy, with the accepted causes for premature death being vascular and respiratory disease. Increased mortality from malignant disease has also been reported. We, therefore, performed a multicenter retrospective cohort study of 1362 patients with acromegaly and investigated the relationships of mortality and cancer incidence with GH levels, duration of disease, and age at diagnosis. The overall cancer incidence rate [standardized incidence ratio, 0.76; 95% confidence interval (CI), 0.60-0.95] was lower than that in the general population of the United Kingdom, and there was no significant increase in site-specific cancer incidence rates. The overall cancer mortality rate was not increased, but the colon cancer mortality rate (standardized mortality ratio, 2.47; 95% CI, 1.31-4.22) was higher than expected. Mortality rates due to colon cancer, all malignant disease, cardiovascular disease and overall mortality were increased with higher posttreatment GH levels (P for trends, <0.02, <0.05, <0.02, and <0.0001). The overall mortality rate in patients with acromegaly with posttreatment GH levels less than 2.5 ng/mL (5 mU/L) was comparable to that in the general population of the United Kingdom (standardized mortality ratio, 1.10; 95% CI, 0.89-1.35). We conclude that high posttreatment GH levels are associated with an increased overall mortality rate and increased mortality rates due to colon cancer, cardiovascular disease, and all malignant disease. Posttreatment GH levels less than 2.5 ng/mL (5 mU/L) result in an overall mortality rate similar to that in the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Determinants of clinical outcome and survival in acromegaly
Rajasoorya, C., Holdaway, I. M., Wrightson, P., Scott, D. J., & Ibbertson, H. K. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03789.x · Cited by 565
Wright, A. D., Hill, D. M., Lowy, C., & Fraser, T. R. (1970) · PubMed · Cited by 529
BENGTSSON, B., EDÉN, S., ERNEST, I., ODÉN, A., & SJÖGREN, B. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb15881.x · Cited by 528
Dopamine Agonists and Pituitary Tumor Shrinkage
BEVAN, J. S., WEBSTER, J., Burke, C. W., & Scanlon, M. F. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-220 · Cited by 469
EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION
ALEXANDER, L., APPLETON, D., HALL, R., ROSS, W. M., & WILKINSON, R. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb03135.x · Cited by 466
An audit of outcome of treatment in acromegaly
(1993) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068816 · Cited by 466
Acromegaly and gastrointestinal cancer
Ron, E., Gridley, G., Hrubec, Z., Page, W., Arora, S., & Fraumeni, J. F. (1991) · Cancer · doi:10.1002/1097-0142(19911015)68:8<1673::aid-cncr2820680802>3.0.co;2-0 · Cited by 250
Vance, M. L., & Harris, A. G. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400080073013 · Cited by 249
Cohort Study Analysis with a FORTRAN Computer Program
COLEMAN, M., DOUGLAS, A., HERMON, C., & PETO, J. (1986) · International Journal of Epidemiology · doi:10.1093/ije/15.1.134 · Cited by 249
Acromegaly, colonic polyps and carcinoma
Jenkins, P. J., Fairclough, P. D., Richards, T., Lowe, D. G., Monson, J., Grossman, A., Wass, J. A. H., & Besser, M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1911029.x · Cited by 224
Colonie Polyps in Patients with Acromegaly
KLEIN, I., GULNAR, P., GAVALER, J. S., & DAVID H., V. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-1-27 · Cited by 165
Benign and Malignant Tumors in Patients With Acromegaly
Barzilay, J. I., Heatley, G. J., & Cushing, G. W. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400080113022 · Cited by 142
Ituarte, E. A., PETRINI, J., & HERSHMAN, J. M. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-5-627 · Cited by 132
Neurosurgical management of acromegaly
Laws, E. R., Piepgras, D. G., Randall, R. V., & Abboud, C. F. (1979) · Journal of neurosurgery · doi:10.3171/jns.1979.50.4.0454 · Cited by 127
Delhougne, B., Deneux, C., Abs, R., Chanson, P., Fierens, H., Laurent‐Puig, P., Duysburgh, I., Stevenaert, A., Tabarin, A., Delwaide, J., et al. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3223 · Cited by 122
Ho, K. K. Y., & Welssberger, A. J. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03787.x · Cited by 109
COLON CANCER AND POLYPS IN ACROMEGALY: INCREASED RISK ASSOCIATED WITH FAMILY HISTORY OF COLON CANCER
BRUNNER, J. E., Johnson, C. C., Zafar, S. U., Peterson, E. L., BRUNNER, J. F., & Mellinger, R. C. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03751.x · Cited by 106
Gastrointestinal tumors in acromegalic patients.
Pines, A., Rozen, P., Ron, E., & Gilat, T. (1985) · PubMed · Cited by 80
Factors determining the long-term outcome of surgery for acromegaly
OSMAN, I. A., James, R., CHATTERJEE, S., MATHIAS, D., & Kendall-Taylor, P. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068874 · Cited by 63
Serum Cortisol Levels in Cushing's Syndrome After Low- and High-Dose Dexamethasone Suppression
Ashcraft, M. W., HERLE, A. J. V., VENER, S. L., & GEFFNER, D. L. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-1-21 · Cited by 52
Ho, P. J., Jaffe, C. A., Friberg, R. D., Chandler, W. F., & Barkan, A. L. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.6.1403 · Cited by 52
Cited by
Acromegaly: An Endocrine Society Clinical Practice Guideline
Katznelson, L., Laws, E. R., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2700 · Cited by 1,786
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Melmed, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062453 · Cited by 1,160
Metadata
- Authors
- Orme, S. M., McNally, R. J. Q., Cartwright, R. A., & Belchetz, P. E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-08
- Volume
- 83
- Issue
- 8
- Pages
- 2730-2734
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2164303686
- Cited by
- 805
- References
- 21
- FWCI
- 24.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.